Markets:

Overview

News

Currencies

International

Treasuries

Ventas, Inc. Common Stock (NY:VTR)

77.33 -0.45 (-0.57%)

Streaming Delayed Price Updated: 11:02 AM EST, Jan 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ventas, Inc. Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

What 4 Analyst Ratings Have To Say About Ventas ↗

February 01, 2023

Via Benzinga

Ventas Appoints J. Justin Hutchens, Executive Vice President, Senior Housing, to Additional Role of Chief Investment Officer

January 23, 2023

From Ventas, Inc.

Via Business Wire

Ventas Announces Fourth Quarter 2022 Earnings Release Date and Conference Call

January 18, 2023

From Ventas, Inc.

Via Business Wire

Ventas Announces Tax Treatment Of 2022 Distributions

January 17, 2023

From Ventas Inc.

Via Business Wire

The Latest Analyst Ratings for Ventas ↗

January 09, 2023

Via Benzinga

8 Analysts Have This to Say About Ventas ↗

November 23, 2022

Via Benzinga

Expert Ratings for Ventas ↗

October 10, 2022

Analysts have provided the following ratings for Ventas (NYSE:VTR) within the last quarter:

Via Benzinga

7 Analysts Have This to Say About Ventas ↗

October 10, 2022

Within the last quarter, Ventas (NYSE:VTR) has observed the following analyst ratings:

Via Benzinga

Ventas Inc. REIT: Relief Rally Gains New Strength ↗

January 09, 2023

While quite a few real estate investment trusts (REITs) are just now coming off of new lows, Ventas Inc. (NYSE: VTR) is up to a three-month high.

Via Benzinga

3 Unloved REIT Sectors That Are On Fire ↗

January 09, 2023

More than 200 publicly traded real estate investment trusts (REITs) across 13 sectors are traded on the stock market, according to the National Association of Real Estate Investment Trusts (Nareit)...

Via Benzinga

5 Must-Buy REITs for Your January Buy List ↗

January 09, 2023

Here are five exceptional REITs to buy that happen to offer consistent growth and healthy passive income for long-term investors right now.

Via InvestorPlace

Cadence and Ardent Health Services Launch Remote Care Management Program to Improve Care and Outcomes for Patients Outside of Clinics

January 04, 2023

From Cadence

Via Business Wire

2 High-Yield Dividend Stocks to Buy Before the End of 2022 ↗

December 15, 2022

These two stocks are positioned for growth in 2023.

Via The Motley Fool

These 2 High-Yield Healthcare REITs Are Holding Up Better Than The Overall Market In 2022 ↗

December 14, 2022

Real estate investment trusts (REITs) operating in the healthcare sector, tend to have a trailing 10-year return of 11.6%, according to SP Global.

Via Benzinga

Ventas Declares Fourth Quarter 2022 Dividend of $0.45 per Common Share

December 07, 2022

From Ventas, Inc.

Via Business Wire

This High-Yield Dividend Stock May Finally Be Ready to Start Growing Again ↗

December 01, 2022

Ventas was hit hard during the early days of the coronavirus pandemic, but it is on the cusp of a recovery.

Via The Motley Fool

Ventas Recognized for Industry ESG Leadership in 2022

November 18, 2022

From Ventas, Inc.

Via Business Wire

Ventas to Participate in Investor Meetings at Nareit’s REITworld 2022 Annual Conference

November 11, 2022

From Ventas, Inc.

Via Business Wire

Ventas Reports 2022 Third Quarter Results

November 03, 2022

From Ventas, Inc.

Via Business Wire

Ventas Announces Third Quarter 2022 Earnings Release Date and Conference Call

October 19, 2022

From Ventas, Inc.

Via Business Wire

Jim Cramer Says Stay Away From This Cybersecurity Company; He's Been 'Against Them The Whole Way Down' ↗

October 11, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said BlackBerry Limited (NYSE: BB) is losing money and he's been "against them the whole way down."

Via Benzinga

Earnings Scheduled For November 3, 2022 ↗

November 03, 2022

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 ↗

November 01, 2022

Upgrades

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022 ↗

October 10, 2022

Upgrades

Via Benzinga

From A to Z: All The REITs Hitting New 52-Week Lows This Week ↗

October 14, 2022

From A to Z: All The REITs Hitting New 52-Week Lows This Week Real estate investment trusts (REITs) — and there are a lot of them — have gone from a New York Stock Exchange favorite to a stock to steer...

Via Benzinga

This Analyst Boosts Price Target On Satsuma Pharmaceuticals By 200%? Plus UBS Predicts $38 For General Motors ↗

October 10, 2022

SVB Leerink raised the price target on Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) from $5 to $15. SVB Leerink analyst Marc Goodman upgraded the stock from Market Perform to Outperform. Satsuma...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

October 10, 2022

During Monday's trading, 528 companies set new 52-week lows.

Via Benzinga

Tilray Brands To Rally Over 45%? Here Are 5 Other Price Target Changes For Monday ↗

October 10, 2022

Cantor Fitzgerald raised Tilray Brands, Inc. (NASDAQ: TLRY) price target from $4.15 to $4.5. Cantor Fitzgerald analyst Pablo Zuanic maintained a Neutral rating on the stock. Tilray Brands shares fell...

Via Benzinga

7 Undervalued REITs to Buy With Serious Profit Potential ↗

October 04, 2022

In investing circles, undervalued REITs are among the most sought-after asset classes, but these ones possess added advantages.

Via InvestorPlace

Ventas to Participate in Investor Meetings at Mizuho Healthcare REIT Conference 2022

October 03, 2022

From Ventas, Inc.

Via Business Wire

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.